Literature DB >> 31345736

FDA approval of GLP-1 receptor agonist (liraglutide) for use in children.

Fida Bacha1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31345736     DOI: 10.1016/S2352-4642(19)30236-6

Source DB:  PubMed          Journal:  Lancet Child Adolesc Health        ISSN: 2352-4642


× No keyword cloud information.
  2 in total

1.  Evaluation of the efficacy of low-dose liraglutide in weight control among Taiwanese non-diabetes patients.

Authors:  Chien-An Chou; Shu-Fen Chuang
Journal:  J Diabetes Investig       Date:  2020-07-17       Impact factor: 4.232

2.  A GLP1 receptor agonist diabetes drug ameliorates neurodegeneration in a mouse model of infantile neurometabolic disease.

Authors:  L Poupon-Bejuit; M P Hughes; W Liu; A Geard; N Faour-Slika; S Whaler; G Massaro; A A Rahim
Journal:  Sci Rep       Date:  2022-08-15       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.